Structure-Guided Optimization of Small-Molecule Folate Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters
Name:
Kiefer_jm1c02114.pdf
Size:
2.375Mb
Format:
PDF
Description:
Article_deposited at PubMedCentral
Name:
Kiefer_medium_jm1c02114_figure ...
Size:
27.43Kb
Format:
GIF image
Description:
Figure 02
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Kiefer, Alexander F.Bousis, Spyridon
Hamed, Mostafa M.
Diamanti, Eleonora
Haupenthal, Jörg
Hirsch, Anna K.H.
Issue Date
2022-07-14Submitted date
2021-12-10
Metadata
Show full item recordAbstract
Here, we report on a potent class of substituted ureidothiophenes targeting energy-coupling factor (ECF) transporters, an unexplored target that is not addressed by any antibiotic in the market. Since the ECF module is crucial for the vitamin transport mechanism, the prevention of substrate uptake should ultimately lead to cell death. By utilizing a combination of virtual and functional whole-cell screening of our in-house library, the membrane-bound protein mediated uptake of folate could be effectively inhibited. Structure-based optimization of our hit yielded low-micromolar inhibitors, whereby the most active compounds showed in addition potent antimicrobial activities against a panel of clinically relevant Gram-positive pathogens without significant cytotoxic effects. © 2022 American Chemical Society.Citation
Kiefer AF, Bousis S, Hamed MM, Diamanti E, Haupenthal J, Hirsch AKH. Structure-Guided Optimization of Small-Molecule Folate Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters. J Med Chem. 2022 Jul 14;65(13):8869-8880. doi: 10.1021/acs.jmedchem.1c02114. Epub 2022 Jun 16. PMID: 35709475; PMCID: PMC9289886.Affiliation
a Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, Saarbrücken, 66123, Germany b Department of Pharmacy, Saarland University, Campus E8.1, Saarbrücken, 66123, Germany c Helmholtz International Lab for Anti-Infectives, Campus E8.1, Saarbrücken, 66123, GermanyPublisher
ACS/ American Chemical SocietyJournal
Journal of Medicinal ChemistryAdditional Links
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc9289886/https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c02114#article_content-right
Type
ArticleOther
Series/Report no.
Volume 65, Issue 13ISSN
00222623EISSN
15204804Sponsors
Horizon 2020 Framework Programme, ERC starting grant 757913, Marie Skłodowska Curie grant agreement no. 665250ae974a485f413a2113503eed53cd6c53
10.1021/acs.jmedchem.1c02114
Scopus Count
The following license files are associated with this item:
- Creative Commons










